Biotechnology
Molecular
Diagnostics
Genetic
Analysis
United
States
Specializing
M&A Advisory
Lazard
Full Credential Description
Sequenom. United States. Announced Date 02/12/2010. Closed Date 07/12/2010. Deal value: $97m. Underwritten registered direct offering of common stock. Industry: Sequenom was a biotechnology company specializing in molecular diagnostics and genetic analysis.